Amylyx Pharmaceuticals, Inc.

Q4 2022 13F Holders

Symbol
AMLX
CUSIP
03237H101
Type
Equity
Class
COM
Num filings
155
Total reported value, excl. options
$1.83 B
Manager Report Date Value ($000) Shares Option Type